Commentary on: A Retrospective Comparison of the Efficacy of Embolization with Imipenem/Cilastatin and Microspheres in the Management of Chronic Shoulder Pain-Reference-Cited by-同舟云学术

Commentary on: A Retrospective Comparison of the Efficacy of Embolization with Imipenem/Cilastatin and Microspheres in the Management of Chronic Shoulder Pain

Published:2023-04-27 Issue:6 Volume:46 Page:758-759
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Fernández Martínez Ana María^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00270-023-03429-7.pdf

Reference4 articles.

1. Finas M, Frandon J, Gremen E, Horteur C, Benassayag M, Lateur G, et al. A retrospective comparison of the efficacy of embolization with imipenem/cilastatin and microspheres in the management of chronic shoulder pain. Cardiovasc Intervent Radiol. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/36826491/.

2. Okuno Y, Matsumura N, Oguro S. Transcatheter arterial embolization using imipenem/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management. J Vasc Interv Radiol. 2013;24:787–92.

3. Yamada K, Jahangiri Y, Li J, Gabr A, Anoushiravani A, Kumagai K, et al. Embolic characteristics of imipenem–cilastatin particles in vitro and in vivo: implications for transarterial embolization in joint arthropathies. J Vasc Interv Radiol Elsevier BV. 2021;32:1031-1039.e2.

4. Bhatia S, Jalaeian H, Kumar J, Acharya V, Shibuya M, Bhatia A, et al. Two-year outcomes comparing embosphere® microspheres versus imipenem cilastatin for genicular artery embolization in patients with moderate to severe knee osteoarthritis. Knee. 2023;41:38–47.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro study of the embolic characteristics of imipenem/cilastatin particles;CVIR Endovascular;2024-03-11